Groundbreaking study finds abortion pill 22 times more dangerous than FDA says

• New Study Reveals Higher Risks: A major study by the Ethics and Public Policy Center found that 10.93% of women who took the abortion pill mifepristone experienced serious adverse events, making it 22 times more dangerous than previously reported by the FDA and the manufacturer Danco.
• Large-Scale Data Used: Unlike earlier FDA data based on 10 clinical trials with about 31,000 participants, this study analyzed real-world insurance claims from over 865,000 women between 2017 and 2023.
• Call for FDA Action: The study’s authors and pro-life advocates are urging the FDA to reinstate original safety protocols, limit mifepristone use to seven weeks of pregnancy, and require in-person clinical visits.
• Political and Advocacy Implications: The findings are fueling renewed demands to reconsider mifepristone’s approval and highlight ongoing opposition to recent regulatory rollbacks allowing telehealth and mail-order access to abortion pills.

Click here to read the full article: Pregnancy Help News – Groundbreaking study finds abortion pill 22 times more dangerous than FDA says